Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$65.8M |
| 2 |
iShares MSCI Japan ETF
EWJ
|
+$65.6M |
| 3 |
Lowe's Companies
LOW
|
+$61.6M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$59.2M |
| 5 |
iShares MSCI India ETF
INDA
|
+$40.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$274M |
| 2 |
iShares MSCI Taiwan ETF
EWT
|
+$93.6M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$50.9M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$48.2M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$37.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 14.45% |
| 2 | Technology | 13.1% |
| 3 | Consumer Discretionary | 12.53% |
| 4 | Healthcare | 11.49% |
| 5 | Industrials | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1276
Genpact
G
$7.29B
| $247K | ﹤0.01% |
+8,580
| New | +$244K |
2017 Q3
0 quarters
|
|
|
BRSS
1277
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $247K | ﹤0.01% |
7,300
+463
| +7% | +$14.2K |
2016 Q4
3 quarters
|
|
1278
AZZ Inc
AZZ
$4B
| $246K | ﹤0.01% |
+5,051
| New | +$251K |
2017 Q3
0 quarters
|
|
1279
EPAM Systems
EPAM
$8.32B
| $246K | ﹤0.01% |
+2,800
| New | +$234K |
2017 Q3
0 quarters
|
|
1280
Kadant
KAI
$3.47B
| $246K | ﹤0.01% |
2,500
-589
| -19% | -$50K |
2017 Q2
1 quarter
|
|
1281
Cabot Corp
CBT
$3.69B
| $245K | ﹤0.01% |
4,383
-59,369
| -93% | -$3.17M |
2015 Q4
7 quarters
|
|
1282
Walker & Dunlop
WD
$1.32B
| $245K | ﹤0.01% |
4,675
-18,158
| -80% | -$885K |
2017 Q2
1 quarter
|
|
|
MRTX
1283
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $245K | ﹤0.01% |
+20,975
| New | +$121K |
2017 Q3
0 quarters
|
|
1284
DELISTED
LivePerson
LPSN
| $244K | ﹤0.01% |
+1,198
| New | +$230K |
2017 Q3
0 quarters
|
|
1285
Abercrombie & Fitch
ANF
$6.32B
| $243K | ﹤0.01% |
+16,810
| New | +$192K |
2017 Q3
0 quarters
|
|
1286
Materion
MTRN
$4.25B
| $241K | ﹤0.01% |
+5,589
| New | +$214K |
2017 Q3
0 quarters
|
|
|
PFNX
1287
DELISTED
Pfenex Inc.
PFNX
| $241K | ﹤0.01% |
79,800
+48,568
| +156% | +$185K |
2017 Q1
2 quarters
|
|
1288
CytomX Therapeutics
CTMX
$445M
| $240K | ﹤0.01% |
13,200
-2,800
| -18% | -$43.7K |
2017 Q2
1 quarter
|
|
1289
Huron Consulting
HURN
$2.68B
| $240K | ﹤0.01% |
+7,007
| New | +$248K |
2017 Q3
0 quarters
|
|
1290
DELISTED
General Cable Corporation
BGC
| $240K | ﹤0.01% |
+12,735
| New | +$228K |
2017 Q3
0 quarters
|
|
|
CSII
1291
DELISTED
Cardiovascular Systems, Inc.
CSII
| $239K | ﹤0.01% |
8,500
-8,041
| -49% | -$245K |
2017 Q2
1 quarter
|
|
|
ADMS
1292
DELISTED
Adamas Pharmaceuticals
ADMS
| $239K | ﹤0.01% |
+11,296
| New | +$207K |
2017 Q3
0 quarters
|
|
1293
Amdocs
DOX
$4.68B
| $238K | ﹤0.01% |
+3,700
| New | +$239K |
2017 Q3
0 quarters
|
|
1294
Federated Hermes
FHI
$4.71B
| $238K | ﹤0.01% |
8,000
-20,637
| -72% | -$580K |
2016 Q4
3 quarters
|
|
1295
HealthStream
HSTM
$856M
| $238K | ﹤0.01% |
+10,195
| New | +$242K |
2017 Q3
0 quarters
|
|
1296
Ferrari
RACE
$72B
| $238K | ﹤0.01% |
2,156
-3,605
| -63% | -$384K |
2017 Q1
2 quarters
|
|
|
CTT
1297
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $238K | ﹤0.01% |
+18,853
| New | +$220K |
2017 Q3
0 quarters
|
|
|
GHDX
1298
DELISTED
Genomic Health, Inc.
GHDX
| $238K | ﹤0.01% |
+7,408
| New | +$234K |
2017 Q3
0 quarters
|
|
1299
Jones Lang LaSalle
JLL
$16.8B
| $236K | ﹤0.01% |
1,912
-823
| -30% | -$102K |
2017 Q2
1 quarter
|
|
1300
Primerica
PRI
$8.9B
| $236K | ﹤0.01% |
2,894
-1,335
| -32% | -$104K |
2017 Q2
1 quarter
|
|
Similar funds
Squarepoint's Q3 2017 Portfolio in Review
As of Q3 2017, Squarepoint held 2,083 positions worth $5.2B, up 2.3% from $5.08B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint's Q3 2017 filing shows 588 new, 511 increased, 480 reduced and 501 closed positions. Its largest new stake was iShares MSCI Japan ETF: 1,203,234 shares worth $67M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $274M.
By sector, the portfolio is most concentrated in Miscellaneous at 14% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- Squarepoint's largest Q3 2017 buy was iShares MSCI Japan ETF: 1,203,234 shares worth $67M.
- Squarepoint added most to Invesco QQQ Trust in Q3 2017, an estimated $65.8M increase.
- Squarepoint's biggest Q3 2017 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $274M.
- Squarepoint fully exited iShares MSCI Taiwan ETF in Q3 2017, selling an estimated $93.6M.
- Squarepoint's ten largest holdings make up 11% of its $5.2B portfolio in Q3 2017.
- Squarepoint opened 588 new positions and closed 501 in Q3 2017.
- Squarepoint's portfolio value rose 2.3% quarter-over-quarter to $5.2B.
Based on Squarepoint's 13F filing for Q3 2017, filed 14 Nov 2017.